TXG

10x Genomics (TXG)

10x Genomics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TXG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/05/23	05 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/05/23	05 : 17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/05/03	05 : 05	PR Newswire (US)	10x Genomics to Present at the BofA Securities 2024 Healthcare Conference	NASDAQ:TXG	10x Genomics Inc
2024/05/01	05 : 05	PR Newswire (US)	10x Genomics Reports First Quarter 2024 Financial Results	NASDAQ:TXG	10x Genomics Inc
2024/04/11	05 : 05	PR Newswire (US)	10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024	NASDAQ:TXG	10x Genomics Inc
2024/03/26	22 : 00	PR Newswire (US)	10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay	NASDAQ:TXG	10x Genomics Inc
2024/03/22	05 : 05	PR Newswire (US)	10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	NASDAQ:TXG	10x Genomics Inc
2024/03/14	05 : 05	PR Newswire (US)	10x Genomics Begins Commercial Shipments of Chromium GEM-X Products	NASDAQ:TXG	10x Genomics Inc
2024/03/07	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/03/05	08 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/27	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/27	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/27	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/23	09 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/23	09 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/23	08 : 59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/21	06 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/21	06 : 05	PR Newswire (US)	10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference	NASDAQ:TXG	10x Genomics Inc
2024/02/16	07 : 33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TXG	10x Genomics Inc
2024/02/16	07 : 16	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TXG	10x Genomics Inc
2024/02/16	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
2024/02/16	06 : 05	PR Newswire (US)	10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024	NASDAQ:TXG	10x Genomics Inc
2024/02/14	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/08	06 : 05	PR Newswire (US)	10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology	NASDAQ:TXG	10x Genomics Inc
2024/02/06	06 : 05	PR Newswire (US)	10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting	NASDAQ:TXG	10x Genomics Inc
2024/01/25	06 : 05	PR Newswire (US)	10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024	NASDAQ:TXG	10x Genomics Inc
2024/01/19	06 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/01/17	08 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/01/17	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc